NeoGenomics, Inc. (NEO) Revenue Growth
NeoGenomics, Inc. (NEO) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 5.95% |
| 2018-12-31 | 7.01% |
| 2019-12-31 | 47.73% |
| 2020-12-31 | 8.71% |
| 2021-12-31 | 8.97% |
| 2022-12-31 | 5.24% |
| 2023-12-31 | 16.07% |
| 2024-12-31 | 11.65% |
| 2025-12-31 | 10.11% |
How NEO compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| EW | Edwards Lifesciences Corporation | 11.55% |
| AMGN | Amgen Inc. | 9.95% |
| UHS | Universal Health Services Inc. | 9.71% |
| VRTX | Vertex Pharmaceuticals Incorporated | 8.90% |
| ABBV | AbbVie Inc. | 8.57% |
These are five companies in the same sector as NEO with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get NeoGenomics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("NEO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NEO | $17.40 | -0.29% | 1.79M |
| 3 | ||||
| 4 | ||||
| 5 |